|
|
Volumn 19, Issue 4, 2011, Pages 627-628
|
|
Redemption for the field of oncolytic virotherapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
ONCOLYTIC VIRUS;
ONCOVEX;
RITUXIMAB;
SORAFENIB;
SUNITINIB;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
BIOTECHNOLOGY;
DRUG INDUSTRY;
DRUG MARKETING;
EDITORIAL;
GENETIC ENGINEERING;
HUMAN;
MELANOMA;
ONCOLYTIC VIROTHERAPY;
|
|
EID: 79953317447
PISSN: 15250016
EISSN: 15250024
Source Type: Journal
DOI: 10.1038/mt.2011.45 Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|
